Chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in progressive versus non-progressive osteoarthritis

Annals of the Rheumatic Diseases

Volumn 56, Issue 2, 1997, Pages 119-122

  Fawthrop, Fiona ^a   Yaqub, Reehana ^a   Belcher, Carolyn ^a   Bayliss, Michael ^b   Ledingham, Joanna ^a   Doherty, Michael ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; EPITOPE; KERATAN SULFATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYNOVIAL FLUID;

EID: 0030939541     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.2.119     Document Type: Article

References (15)

1. Mehmet H, Scudder P, Tang PW, Hounsell EF, Caterson B, Feizi T. The antiogenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta- or larger oligosaccharides of the poly (N-acetyllactosamine) series. Eur J Biochem 1986; 157:385-91.
2. Thonar EJ-MA, Lenz ME, Klintworth GK, Caterson B, Pachman LM, Glickman P, et al. Quantification of keratan sulphate in blood as a marker of cartilage metabolism. Arthritis Rheum 1985;28:1367-76.
3. Mehraban F, Finegan CK, Moskowitz RW. Serum keratan sulphate. Quantitative and qualitative comparisons in inflammatory versus non inflammatory arthritides. Arthritis Rheum 1991;34:383-92.
4. Campion GV, McCrae F, Schnitzer TJ, Lenz Me, Dieppe PA, Thonar EJ-MA. Levels of keratan sulphate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum 1991;34:1254-9.
5. Sweet MBE, Coelho A, Schnitzler TJ, Lenz ME, Jakim I, Kuettner KE, et al. Serum keratan sulfate levels in osteoarthritis patients. Arthritis Rheum 1988;31:557-60.
6. Caterson B, Mahmoodian F, Sorrell JM, Hardingham TE, Bayliss MT, Carney ST, et al. Modulation of native chondroitin sulphate structure in tissue development and in disease. J Cell Sci 1990;97:411-7.
7. Slater RR, Bayliss MT, Lachiewicz PF, Visco DM, Caterson B. Monoclonal antibodies that detect biochemical markers of arthritis in humans. Arthritis Rheum 1995;38:655-9.
8. Hazell PK, Dent C, Fairclough JA, Bayliss MT, Hardingham TE. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis Rheum 1995;38:953-9.
9. Ledingham J, Regan M, Jones A, Doherty M. Factors affecting radiographic progression of knee osteoarthritis. Ann Rheum Dis 1995;54:53-7.
10. Kellgren J, Lawrence JS. Radiological assessment of osteoarthritis. Ann Rheum Dis 1957;16:494-502.
11. Ratcliffe A, Shurety W, Caterson B. The quantitation of a native chondroitin sulphate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis an disuse atrophy. Arthritis Rheum 1993; 36:543-51.
12. Fosang AJ, Hey NJ, Carney SL, Hardingham TE. An ELISA plate based assay for hyaluronan using biotinylated G1 domain (HA-binding region). Matrix 1990;10:306-13.
13. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochem Biophys Acta 1986;883:173-7.
14. Spector TD, Woodward L, Hall GM, Hammond A, Williams A, Butler MG, et al. Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseases. Ann Rheum Dis 1992;51:1134-7.
15. Doherty M, Belcher C, Regan M, Jones A, Ledingham J. Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of knee osteoarthritis. Ann Rheum Dis 1996;55:432-6.